Terns Pharmaceuticals Logo

Terns Pharmaceuticals

🇺🇸
TERN
US8808811074

Terns Pharmaceuticals is a US biopharmaceutical company dedicated to developing innovative medicines for liver, metabolic, and oncology diseases. Through clinical research and development, the company aims to deliver groundbreaking therapies to patients worldwide, focusing on addressing unmet medical needs in these critical therapeutic areas.

Next Quarterly Earnings

Stock Price

Frequently asked questions

When did Terns Pharmaceuticals last report quarterly earnings?

Terns Pharmaceuticals last reported quarterly earnings on 11/18/2025 (Q3 2025).

How often has Terns Pharmaceuticals beaten expectations?

Terns Pharmaceuticals has beaten analyst EPS estimates in 4 of its last 4 evaluated quarters (beat rate: 100%).

How do I add the Terns Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2025
Beat
Estimate:-$0.28
Actual:-$0.24
Difference:+$0.04
Q3 2025
Beat
Estimate:-$0.30
Actual:-$0.27
Difference:+$0.03
Q1 2025
Beat
Estimate:-$0.29
Actual:-$0.26
Difference:+$0.03
Q4 2024
Beat
Estimate:-$0.27
Actual:-$0.26
Difference:+$0.01

Earnings statistics

Estimates vs. results

4/4
Quarters above estimates
100%
Beat rate
+0.1%
Avg. EPS surprise

Basis: 4 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Terns Pharmaceuticals
Ticker Symbol
TERN
ISIN
US8808811074
Country
🇺🇸
USA
Sector